| Syncytia formation by SARS‐CoV‐2‐infected cells J Buchrieser, J Dufloo, M Hubert, B Monel, D Planas, MM Rajah, ... The EMBO journal 40 (3), e107405, 2021 | 450 | 2021 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 336* | 2020 |
| SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation MM Rajah, M Hubert, E Bishop, N Saunders, R Robinot, L Grzelak, ... The EMBO journal 40 (24), e108944, 2021 | 165 | 2021 |
| Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ... Nature communications 14 (1), 824, 2023 | 135 | 2023 |
| Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies J Dufloo, L Grzelak, I Staropoli, Y Madec, L Tondeur, F Anna, S Pelleau, ... Cell Reports Medicine 2 (5), 2021 | 82 | 2021 |
| Structural basis for broad HIV-1 neutralization by the MPER-specific human broadly neutralizing antibody LN01 D Pinto, C Fenwick, C Caillat, C Silacci, S Guseva, F Dehez, C Chipot, ... Cell host & microbe 26 (5), 623-637. e8, 2019 | 62 | 2019 |
| HIV-1 cell-to-cell transmission and broadly neutralizing antibodies J Dufloo, T Bruel, O Schwartz Retrovirology 15, 1-14, 2018 | 62 | 2018 |
| Conformational plasticity in broadly neutralizing HIV-1 antibodies triggers polyreactivity J Prigent, A Jarossay, C Planchais, C Eden, J Dufloo, A Kök, V Lorin, ... Cell reports 23 (9), 2568-2581, 2018 | 45 | 2018 |
| Diverse effects of interferon alpha on the establishment and reversal of HIV latency RM Van der Sluis, JM Zerbato, JW Rhodes, RD Pascoe, A Solomon, ... PLoS pathogens 16 (2), e1008151, 2020 | 44 | 2020 |
| Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA. 1 and BA. 2 C Planchais, I Fernández, T Bruel, GD de Melo, M Prot, M Beretta, ... Journal of Experimental Medicine 219 (7), 2022 | 41 | 2022 |
| Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells J Dufloo, C Planchais, S Frémont, V Lorin, F Guivel-Benhassine, K Stefic, ... Nature Communications 13 (1), 630, 2022 | 27 | 2022 |
| Anti‐HIV‐1 antibodies trigger non‐lytic complement deposition on infected cells J Dufloo, F Guivel‐Benhassine, J Buchrieser, V Lorin, L Grzelak, ... EMBO reports 21 (2), e49351, 2020 | 25 | 2020 |
| Flow cytometry analysis of HIV-1 Env conformations at the surface of infected cells and virions: role of Nef, CD4, and SERINC5 I Staropoli, J Dufloo, A Ducher, PH Commere, A Sartori-Rupp, S Novault, ... Journal of Virology 94 (6), 10.1128/jvi. 01783-19, 2020 | 21 | 2020 |
| Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis DA Spencer, BS Goldberg, S Pandey, T Ordonez, J Dufloo, P Barnette, ... Nature communications 13 (1), 662, 2022 | 20 | 2022 |
| Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers LM Molinos-Albert, V Lorin, V Monceaux, S Orr, A Essat, J Dufloo, ... Nature Communications 13 (1), 1944, 2022 | 12 | 2022 |
| Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1 F Marziali, M Delpeuch, A Kumar, R Appourchaux, J Dufloo, K Tartour, ... Journal of Virology 95 (18), 10.1128/jvi. 00439-21, 2021 | 8 | 2021 |
| Revisiting an IgG Fc loss-of-function experiment: the role of complement in HIV broadly neutralizing antibody b12 activity BS Goldberg, CI Kaku, J Dufloo, T Bruel, O Schwartz, DA Spencer, ... Mbio 12 (5), 10.1128/mbio. 01743-21, 2021 | 7 | 2021 |
| Complement contributes to antibody-mediated protection against repeated SHIV challenge BS Goldberg, DA Spencer, S Pandey, T Ordonez, P Barnette, Y Yu, L Gao, ... Proceedings of the National Academy of Sciences 120 (20), e2221247120, 2023 | 3 | 2023 |
| Viral entry is a weak barrier to zoonosis J Dufloo, I Andreu-Moreno, A Valero-Rello, R Sanjuán bioRxiv, 2024.01. 22.576693, 2024 | 1 | 2024 |
| Cell type-specific adaptation of the SARS-CoV-2 spike M Carrascosa-Saez, MC Marques, IBV-COVID19-Pipeline, R Geller, ... bioRxiv, 2023.12. 20.572504, 2023 | 1 | 2023 |
Timothée BruelInstitut PasteurAdresse e-mail validée de pasteur.fr
